AnandaniNellanAnandani Nellan39.74403510000000-104.8360594000000011967Nellan, AnandaniAsst Professor Adjointprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMichaelVerneris/eEDZ7y5tWTHPhg4fnnekVFGSoYfD0+wHFBWvvLDHw==Michael Richard Verneris39.74403510000000-104.8360594000000011838Verneris, MichaelProfessor13065 East 17th Avenue2TCHChildren's Hospital13065 East 17th AvenueAurora80045-2532COMichaelNottinghamMichael Todd Nottingham39.74403510000000-104.8360594000000011965Nottingham, MichaelSenior Instructor0.8371160.0085867992research areas0.8138380.040702124coauthor of26.28922.8482260similar to1115selected publicationsAuthorship 1478031Authorship 1478681026810774Burris AM, Ballew BJ, Kentosh JB, Turner CE, Norton SA, Giri N, Alter BP, Nellan A, Gamper C, Hartman KR, Savage SAPediatric neurologyBurris AM, Ballew BJ, Kentosh JB, Turner CE, Norton SA, Giri N, Alter BP, Nellan A, Gamper C, Hartman KR, Savage SA. Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up. Pediatr Neurol. 2016 Mar; 56:62-68.e1.Pediatr Neurol2015-12-19T00:00:002015Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up.26335422Nellan A, Lee DWCurrent opinion in hematologyNellan A, Lee DW. Paving the road ahead for CD19 CAR T-cell therapy. Curr Opin Hematol. 2015 Nov; 22(6):516-20.Curr Opin Hematol2015-11-01T00:00:002015Paving the road ahead for CD19 CAR T-cell therapy.DejeneTufaDejene Milkessa Tufa39.74403510000000-104.8360594000000012160Tufa, DejeneResearch Instructor1Professor3Asst Professor2Assoc Professor4InstructorMasanoriHayashiMasanori Hayashi39.74403510000000-104.8360594000000013355Hayashi, MasanoriAsst ProfessorAuthorship 1752131029350470Witt DA, Donson AM, Amani V, Moreira DC, Sanford B, Hoffman LM, Handler MH, Levy JMM, Jones KL, Nellan A, Foreman NK, Griesinger AMPediatric blood & cancerWitt DA, Donson AM, Amani V, Moreira DC, Sanford B, Hoffman LM, Handler MH, Levy JMM, Jones KL, Nellan A, Foreman NK, Griesinger AM. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy. Pediatr Blood Cancer. 2018 05; 65(5):e26960.Pediatr Blood Cancer2018-01-19T00:00:002018Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.TerryFryTerry J Fry39.74403510000000-104.8360594000000013796Fry, TerryProfessorAuthorship 180626129712574Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DWJournal for immunotherapy of cancerNellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW. Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer. 2018 04 30; 6(1):30.J Immunother Cancer2018-04-30T00:00:002018Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells.Authorship 183117129954750Nellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KEBloodNellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KE. Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. Blood. 2018 08 09; 132(6):662-666.Blood2018-06-28T00:00:002018Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques.D001932Disorders23210160.547325Brain NeoplasmsD010900Disorders17230.978942Pituitary DiseasesD048493Chemicals & Drugs842040.840524Proto-Oncogene Proteins B-rafAuthorship 194163330655315Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, Zhu Z, Croix BS, Delaidelli A, Sekunova A, Bonvini E, Mitra SS, Quezado MM, Majeti R, Monje M, Sorensen PHB, Maris JM, Mackall CLClinical cancer research : an official journal of the American Association for Cancer ResearchMajzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, Zhu Z, Croix BS, Delaidelli A, Sekunova A, Bonvini E, Mitra SS, Quezado MM, Majeti R, Monje M, Sorensen PHB, Maris JM, Mackall CL. CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clin Cancer Res. 2019 04 15; 25(8):2560-2574.Clin Cancer Res2019-01-17T00:00:002019CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.ONC GENERAL OPERATIONSD006646Disorders28360.957282Histiocytosis, Langerhans-CellD019572Disorders14220.962826Retinal NeoplasmsSOM-MEDSOM-PEDSHematologyOncUniversity of Colorado Denver - Anschutz Medical CampusDavidCamidgeDavid Ross Camidge39.74273230000000-104.839191400000002375Camidge, DavidProfessorRajeevVibhakarRajeev Vibhakar39.74403510000000-104.836059400000003220Vibhakar, RajeevProfessorSuzanneSmolikSuzanne Smolik39.74403510000000-104.836059400000003977Smolik, SuzanneAsst ProfessorNicholasForemanNicholas K Foreman39.74403510000000-104.83605940000000664Foreman, NicholasProfessorJeanMulcahy LevyJean M. Mulcahy Levy39.74403510000000-104.836059400000005635Mulcahy Levy, JeanAssociate ProfessorAuthorship 207823631515514Zahedi S, Fitzwalter BE, Morin A, Grob S, Desmarais M, Nellan A, Green AL, Vibhakar R, Hankinson TC, Foreman NK, Mulcahy Levy JMCell death & diseaseZahedi S, Fitzwalter BE, Morin A, Grob S, Desmarais M, Nellan A, Green AL, Vibhakar R, Hankinson TC, Foreman NK, Mulcahy Levy JM. Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells. Cell Death Dis. 2019 09 12; 10(9):679.Cell Death Dis2019-09-12T00:00:002019Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells.Authorship 209787531595628Lake JA, Donson AM, Prince E, Davies KD, Nellan A, Green AL, Mulcahy Levy J, Dorris K, Vibhakar R, Hankinson TC, Foreman NK, Ewalt MD, Kleinschmidt-DeMasters BK, Hoffman LM, Gilani APediatric blood & cancerLake JA, Donson AM, Prince E, Davies KD, Nellan A, Green AL, Mulcahy Levy J, Dorris K, Vibhakar R, Hankinson TC, Foreman NK, Ewalt MD, Kleinschmidt-DeMasters BK, Hoffman LM, Gilani A. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. Pediatr Blood Cancer. 2020 01; 67(1):e28028.Pediatr Blood Cancer2019-10-08T00:00:002019Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.Authorship 221571132506370Nellan A, Wright E, Campbell K, Davies KD, Donson AM, Amani V, Judd A, Hemenway MS, Raybin J, Foreman NK, Rush S, Dorris KJournal of neuro-oncologyNellan A, Wright E, Campbell K, Davies KD, Donson AM, Amani V, Judd A, Hemenway MS, Raybin J, Foreman NK, Rush S, Dorris K. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma. J Neurooncol. 2020 Jul; 148(3):569-575.J Neurooncol2020-06-06T00:00:002020Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.KathleenDorrisKathleen McCarthy O'Toole Dorris39.74403510000000-104.836059400000007954Dorris, KathleenAssociate ProfessorAuthorship 227762132930721Nellan A, Bodlak A, Mirsky DM, Mulcahy Levy J, Garrington TP, Foreman NK, Gilani A, Hayashi MJournal of neuropathology and experimental neurologyNellan A, Bodlak A, Mirsky DM, Mulcahy Levy J, Garrington TP, Foreman NK, Gilani A, Hayashi M. ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients. J Neuropathol Exp Neurol. 2020 12 04; 79(12):1313-1319.J Neuropathol Exp Neurol2020-12-04T00:00:002020ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients.Authorship 2289141133063010Grob ST, Nobre L, Campbell KR, Davies KD, Ryall S, Aisner DL, Hoffman L, Zahedi S, Morin A, Crespo M, Nellan A, Green AL, Foreman N, Vibhakar R, Hankinson TC, Handler MH, Hawkins C, Tabori U, Kleinschmidt-DeMasters BK, Mulcahy Levy JMNeuro-oncology advancesGrob ST, Nobre L, Campbell KR, Davies KD, Ryall S, Aisner DL, Hoffman L, Zahedi S, Morin A, Crespo M, Nellan A, Green AL, Foreman N, Vibhakar R, Hankinson TC, Handler MH, Hawkins C, Tabori U, Kleinschmidt-DeMasters BK, Mulcahy Levy JM. Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa103.Neurooncol Adv2020-08-24T00:00:002020Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.Authorship 241517434077540Riemondy KA, Venkataraman S, Willard N, Nellan A, Sanford B, Griesinger AM, Amani V, Mitra S, Hankinson TC, Handler MH, Sill M, Ocasio J, Weir SJ, Malawsky DS, Gershon TR, Garancher A, Wechsler-Reya RJ, Hesselberth JR, Foreman NK, Donson AM, Vibhakar RNeuro-oncologyRiemondy KA, Venkataraman S, Willard N, Nellan A, Sanford B, Griesinger AM, Amani V, Mitra S, Hankinson TC, Handler MH, Sill M, Ocasio J, Weir SJ, Malawsky DS, Gershon TR, Garancher A, Wechsler-Reya RJ, Hesselberth JR, Foreman NK, Donson AM, Vibhakar R. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro Oncol. 2022 02 01; 24(2):273-286.Neuro Oncol2022-02-01T00:00:002022Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.34693296Nellan A, Fry TJNature cancerNellan A, Fry TJ. Optimizing CARs for ocular delivery. Nat Cancer. 2020 10; 1(10):939-940.Nat Cancer2020-10-12T00:00:002020Optimizing CARs for ocular delivery.Authorship 2523471Authorship 258030235265526Shalabi H, Nellan A, Shah NN, Gust JFrontiers in oncologyShalabi H, Nellan A, Shah NN, Gust J. Immunotherapy Associated Neurotoxicity in Pediatric Oncology. Front Oncol. 2022; 12:836452.Front Oncol2022-02-21T00:00:002022Immunotherapy Associated Neurotoxicity in Pediatric Oncology.Authorship 264012435731362Greer HR, Miller K, Samay S, Nellan A, Green ALJournal of neuro-oncologyGreer HR, Miller K, Samay S, Nellan A, Green AL. Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis. J Neurooncol. 2022 Sep; 159(2):301-308.J Neurooncol2022-06-22T00:00:002022Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Asst ProfessorAsst Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Senior InstructorSenior Instructortrue1Associate ProfessorAssociate Professortrue1Asst ProfessorAsst Professortrue1ProfessorProfessortrue1Asst Professor AdjointAsst Professor Adjointtrue1Research InstructorResearch Instructortrue1ProfessorProfessorAdamGreenAdam L Green39.74403510000000-104.836059400000009131Green, AdamAssociate Professor